Attached files
| file | filename |
|---|---|
| EX-99.1 - PRESS RELEASE - KINDRED HEALTHCARE, INC | dex991.htm |
| EX-10.1 - AMENDMENT NO. 2 AND JOINDER AGREEMENT - KINDRED HEALTHCARE, INC | dex101.htm |
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): December 10, 2010
KINDRED HEALTHCARE, INC.
(Exact name of registrant as specified in its charter)
| Delaware | 001-14057 | 61-1323993 | ||
| (State or other jurisdiction of incorporation or organization) |
(Commission File Number) |
(IRS Employer Identification No.) |
680 South Fourth Street
Louisville, Kentucky
(Address of principal executive offices)
40202-2412
(Zip Code)
Registrant’s telephone number, including area code: (502) 596-7300
Not Applicable
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation to the registrant under any of the following provisions:
| ¨ | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
| ¨ | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
| ¨ | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
| ¨ | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Item 1.01 Entry into a Material Definitive Agreement.
On December 10, 2010, Kindred Healthcare, Inc. (the “Company”) entered into an amendment and joinder agreement (the “Amendment”) to its Second Amended and Restated Credit Agreement dated as of July 18, 2007 among the Company, the Lenders party thereto, and JPMorgan Chase Bank, N.A., as Administrative Agent and Collateral Agent (the “Credit Facility”).
The Amendment increases the amount of commitments under the Credit Facility by $100 million increasing the aggregate amount of credit under the Credit Facility from $500 million to $600 million. In addition, the Amendment increases certain interest rate pricing under the Credit Facility by 50 basis points and provides for the delivery of certain additional documentation requirements.
A copy of the Amendment is attached hereto as Exhibit 10.1.
Item 7.01. Regulation FD Disclosure.
Incorporated by reference is a press release issued by the Company on December 13, 2010, which is attached hereto as Exhibit 99.1. This information is being furnished under Item 7.01 and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, or otherwise subject to the liability of such section.
Item 9.01.
| (d) | Exhibits |
| Exhibit 10.1 |
Amendment No. 2 and Joinder Agreement to the Second Amended and Restated Credit Agreement dated as of July 18, 2007 among the Company, the Lenders party thereto, and JPMorgan Chase Bank, N.A., as Administrative Agent and Collateral Agent. | |
| Exhibit 99.1 |
Press release dated December 13, 2010. | |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereto duly authorized.
| Date: December 13, 2010 | By: | /s/ Joseph L. Landenwich | ||
| Joseph L. Landenwich | ||||
| Senior Vice President, Corporate Legal Affairs | ||||
| and Corporate Secretary |